Newest Science Center Residents Are Developing Technologies to 3D Print Organs and Diagnose and Treat Cancer

PHILADELPHIA–(August 10, 2015) – From 3D bioprinters to liquid biopsies, the five newest residents of the University City Science Center’s Port business incubator are reimagining healthcare.

Biobots is the future of regenerative medicine that is personalized – a high-resolution desktop 3D bioprinter that builds functional three-dimensional living tissue. This low-cost, desktop bioprinter gives big and small companies or institutions such as university research labs, a chance to develop 3D organ models with human cells in their own lab.

Headquartered in London with an office in Boston, Freenome is establishing a satellite office in Philadelphia. The early-stage company is developing an efficient, accurate and cost-effective “liquid biopsy” method of the future. The Freenome diagnosis platform utilizes the power of next-generation sequencing to provide non-invasive, accurate and early detection of cancer – from 1 milliliter of blood.

Click here to read the full press details.


©2017 PACT All Rights Reserved